Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
02/1996
02/22/1996WO1996004795A1 Compositions and methods treating animals infested with ectoparasites
02/22/1996WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds
02/22/1996CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds
02/21/1996EP0697011A1 Large potassium bicarbonate crystals and process for the preparation thereof
02/21/1996CN1117079A Siquan (strontium spring) white spirit and its making method
02/21/1996CN1116949A Chinese herb medicine for external use of gynecopathy
02/21/1996CN1116937A Chinese herb medicine preparation for treating prostate hyperplasia and its preparing method
02/21/1996CN1116927A Amino acid whole nutrient and its producing process
02/20/1996US5492713 Nutriment preparation
02/20/1996US5492693 Water, sea salt and a skin conditioner
02/20/1996US5492692 Blend of nonoxynol oligomers, polyvinylpyrrolidone and iodine
02/20/1996US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza
02/20/1996CA2029015C Pharmaceutical compositions for treating gastrointestinal distress
02/15/1996WO1996003996A1 Deuterium-containing pharmaceutical compositions for destroying tumors
02/15/1996WO1996003965A1 Method for treating non-ocular epithelial disorders
02/15/1996WO1996003881A1 Strongly acidic sterile water containing low-concentration hypochlorous acid, method of forming strongly acidic sterile water containing low-concentration hypochlorous acid, apparatus therefor, and apparatus for forming and delivering strongly acidic sterile water containing low-concentration hypochlorous acid
02/15/1996WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
02/15/1996CA2196671A1 Deuterium-containing pharmaceutical compositions for destroying tumors
02/14/1996EP0696197A1 Analgesic anaesthetic compositions
02/14/1996CN1116629A Monomeric insulin analog formulations
02/14/1996CN1116542A Medicine and food for resisting electromagnetic radiation
02/14/1996CN1030964C Task-masking composition of bitter pharmaceutical agents
02/13/1996US5490985 Extended duration antacid product
02/13/1996US5490984 Injecting wound healing agents into defective area
02/08/1996WO1996003148A1 Method and drug for treating diabetes
02/08/1996WO1996003139A1 Use of nitric oxide or nitric oxide adducts to preserve platelets
02/08/1996WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients
02/08/1996WO1996003129A1 Method of treating sweat-related conditions
02/08/1996WO1995022611A3 Methods and compositions for stimulating bone cells
02/08/1996DE4427690A1 Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum Deuterium-containing pharmaceutical composition as a cytostatic or tumor therapeutic agent
02/08/1996CA2193852A1 Method of treating sweat-related conditions
02/07/1996EP0695180A1 Novel medical use for gaba agonists
02/07/1996CN1116206A Platinum complex and malignant tumor treating drug containing the same
02/07/1996CN1116119A Internal guide therapeutic medicine for rheumatoid disease and making method
02/07/1996CN1116113A Medicinal composition for eye diseases
02/06/1996US5489609 Liver disorder, hepatitis, antiulcer agent
02/06/1996US5489441 Method for suppressing immune response associated with psoriasis, contact dermatitis and diabetes mellitus
02/06/1996US5489435 Composition for treatment of abnormal conditions of the epithelium of bodily orifices
02/01/1996WO1996002288A1 Process for preventing activation of enzyme systems in haemodialysis and in similar procedures with extracorporeal blood circulation
02/01/1996WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis
02/01/1996WO1996002264A2 Chlorine dioxide-containing compositions for use in the eye
02/01/1996WO1996002263A1 Blood sugar regulating compositions containing inulin and one or more metal complexes
02/01/1996WO1996002262A2 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids
02/01/1996WO1996002261A1 Use of magnesium hydroxide as a stool softener
02/01/1996WO1996002241A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
02/01/1996CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis
02/01/1996CA2194991A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
01/1996
01/31/1996EP0693930A1 Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias
01/31/1996EP0693928A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
01/31/1996EP0693919A1 Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt
01/31/1996EP0693878A1 Iodine barrier teat dip
01/31/1996EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
01/31/1996CN1115644A Dispensation and production of growth promoter for farm animals
01/30/1996US5487916 Method for coating particles in a spray-drying plant
01/30/1996US5487906 Method of forming stable aqueous solutions of stannous compounds
01/30/1996US5487897 Thermoplastic polymer, in vivo coagulation, drug delivery, wound healing, tissue regeneration
01/30/1996CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients
01/27/1996CA2154860A1 Oral care products containing zinc-polyamine complex and pyrophosphate
01/25/1996WO1996001645A1 Use of muramyl peptide compounds
01/25/1996WO1996001638A1 Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
01/25/1996CA2194678A1 Use of muramyl peptide compounds
01/24/1996EP0693457A1 Process for the purification of magnesium hydroxyde
01/24/1996EP0692984A1 Systemic effects of nitric oxide inhalation
01/24/1996EP0692965A1 Method and composition for treatment of osteoporosis
01/24/1996EP0692959A1 Use of water-soluble magnesium salts in preparations for external application, and new combination preparations containing such salts
01/24/1996CN1115236A Special effective medicine for sore, ulcer and haemorrhoids
01/24/1996CN1115234A Magnetic inorganic medicine
01/23/1996US5486347 Antiperspirant composition
01/23/1996US5485827 Providing nitrogen oxide for breathing
01/23/1996CA1337970C Antibacterial adhesive composition
01/20/1996CA2154201A1 Use of magnesium hydroxide as a stool softener
01/18/1996WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays
01/18/1996WO1996001272A1 Helicobacter proteins and vaccines
01/18/1996WO1996001119A1 Antimicrobial compositions useful for medical applications
01/18/1996WO1996001118A1 Biochemically balanced peritoneal dialysis solutions
01/18/1996WO1996001109A1 Clavulanate pharmaceutical formulations
01/18/1996DE4424676A1 Effervescent aluminium contg. antacid compsns.
01/18/1996CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays
01/17/1996EP0692457A2 A hexagonal molecular structure water manufacturing apparatus and a method thereof
01/17/1996EP0692255A2 Antacid preparation with improved safety profile
01/17/1996EP0692254A1 Medicine for the topical treatment of skin
01/17/1996EP0691814A1 Method and composition for treatment of osteoporosis
01/17/1996EP0522128B1 Water-dispersible tablets
01/17/1996CN1114882A Medicine for the topical treatment of skin
01/17/1996CN1114881A Medicine containing multiple trace elements for neurasthenia
01/16/1996US5484913 Surgical equipment
01/16/1996US5484612 Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
01/16/1996CA2074454C Medicine based on neutralized sulphur derivatives
01/16/1996CA1337928C Topically applied gold organic complex
01/16/1996CA1337927C Suppression of eczematous dermatitis by calcium transport inhibition
01/14/1996CA2153567A1 Antacid formulation having an improved safety profile
01/11/1996WO1996000566A1 A mouldable alum composition
01/10/1996EP0690722A1 Composition and method for reducing toxicity of biologically-active factors
01/10/1996EP0690718A1 Peritoneal dialysis solutions containing maltodextrins and amino acids
01/10/1996CN1114583A Colour-restoring ointment for treating burn or scald
01/10/1996CN1114575A Fangbing Jianshenbao-a health-care product capable of preventing disease
01/09/1996US5482707 Drinking slurry through coated straw; taste
01/09/1996US5482053 Condom lubricants containing zinc as an anti-viral agent
01/09/1996CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use
01/08/1996CA2127573A1 Vasotonic treatment for migraines